Corient Private Wealth LLC Lowers Position in Encompass Health Co. (NYSE:EHC)

Corient Private Wealth LLC lowered its position in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 21.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,963 shares of the company's stock after selling 4,270 shares during the period. Corient Private Wealth LLC's holdings in Encompass Health were worth $1,474,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp grew its holdings in shares of Encompass Health by 0.7% during the third quarter. State Street Corp now owns 3,025,769 shares of the company's stock worth $292,410,000 after purchasing an additional 21,329 shares during the last quarter. Geode Capital Management LLC grew its holdings in Encompass Health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 1,673,610 shares of the company's stock worth $161,781,000 after acquiring an additional 20,547 shares during the last quarter. Copeland Capital Management LLC increased its position in Encompass Health by 0.7% in the 4th quarter. Copeland Capital Management LLC now owns 1,293,098 shares of the company's stock valued at $119,418,000 after acquiring an additional 8,548 shares during the period. Point72 Asset Management L.P. raised its stake in shares of Encompass Health by 2,458.5% during the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company's stock valued at $83,990,000 after acquiring an additional 835,135 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new position in shares of Encompass Health during the fourth quarter worth $77,944,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Remove Ads

Insider Transactions at Encompass Health

In related news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now owns 69,164 shares in the company, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 2.10% of the company's stock.

Encompass Health Stock Up 0.2 %

Encompass Health stock traded up $0.21 during mid-day trading on Friday, reaching $101.35. The stock had a trading volume of 143,264 shares, compared to its average volume of 653,489. Encompass Health Co. has a fifty-two week low of $78.53 and a fifty-two week high of $104.55. The stock's 50-day simple moving average is $98.55 and its 200-day simple moving average is $97.31. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.04 and a current ratio of 1.05. The firm has a market capitalization of $10.21 billion, a PE ratio of 22.72, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92.

Encompass Health (NYSE:EHC - Get Free Report) last posted its earnings results on Thursday, February 6th. The company reported $1.17 earnings per share for the quarter, topping analysts' consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. On average, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health's dividend payout ratio is 15.25%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on EHC. KeyCorp raised their target price on Encompass Health from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Monday, February 10th. Royal Bank of Canada restated an "outperform" rating and set a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. StockNews.com upgraded Encompass Health from a "hold" rating to a "buy" rating in a report on Saturday, February 15th. Barclays raised their price target on shares of Encompass Health from $116.00 to $118.00 and gave the stock an "overweight" rating in a report on Friday, February 7th. Finally, William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a research report on Friday, February 7th. Ten research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $107.67.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.